Onco-gastroenterology is defined as a collaborative subspecialty of Gastroenterology that is dedicated to the unique needs of individuals with or at risk of cancer, with a focus on maintaining and managing their digestive and liver health throughout their clinical course.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
de-Madaria, E. et al. The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project). Lancet Gastroenterol. Hepatol. 7, 485–494 (2022).
Grover, S., Lim, R. M., Blumberg, R. S. & Syngal, S. Oncogastroenterology. J. Clin. Oncol. 34, 1154–1155 (2016).
Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
Trapani, D. et al. Distribution of the workforce involved in cancer care: a systematic review of the literature. ESMO Open 6, 100292 (2021).
Wadhwa, V., Patel, N., Grover, D., Ali, F. S. & Thosani, N. Interventional gastroenterology in oncology. CA Cancer J. Clin. 73, 286–319 (2023).
Andreyev, J. et al. British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer. Gut https://doi.org/10.1136/gutjnl-2024-333812 (2025).
Stec, N. E. & Walbert, T. Neuro-oncology and supportive care: the role of the neurologist. Neurol. Sci. 43, 939–950 (2022).
Winawer, S. J. et al. The future role of the gastroenterologist in digestive oncology: an international perspective. Gastroenterology 141, e13–e21 (2011).
Tabrizian, P., Abdelrahim, M. & Schwartz, M. Immunotherapy and transplantation for hepatocellular carcinoma. J. Hepatol. 80, 822–825 (2024).
Rezaee-Zavareh, M. S. et al. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: a systematic review and individual patient data meta-analysis. J. Hepatol. 82, 107–119 (2025).
Marín, J. I. et al. The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma. Ann. Hepatol. 28, 101112 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Lui, R., Dhanasekaran, R., Tan, Y.B. et al. Redefining cancer care: the case for an onco-gastroenterology subspecialty. Nat Rev Gastroenterol Hepatol 22, 459–461 (2025). https://doi.org/10.1038/s41575-025-01076-6
Published:
Issue date:
DOI: https://doi.org/10.1038/s41575-025-01076-6